In a case of Novartis against Pharmathen, the Amsterdam Court of Appeal confirmed on 26 March 2024 that Pharmathen will have to pay EUR 7,500,000 in fines for breach of an injunction which had been imposed for patent infringement. In this article in BioScience Law Review, Jaap Bremer and Maurits Tol discuss this ruling.
21 October 2024
Reading time: 1 minutes